Murli Krishna Pharma Profile
Key Indicators
- Authorised Capital ₹ 32.50 Cr
as on 20-12-2024
- Paid Up Capital ₹ 5.39 Cr
as on 20-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 81.68 Cr
as on 20-12-2024
- Satisfied Charges ₹ 13.76 Cr
as on 20-12-2024
About Murli Krishna Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.50 Cr and a paid-up capital of Rs 5.39 Cr.
The company currently has active open charges totaling ₹81.68 Cr. The company has closed loans amounting to ₹13.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Seetamahalaxmi Challa, Vijay Kalyanasundaram, Satya Vadlamani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230PN2004PTC206917
- Company No.
145510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2004
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Murli Krishna Pharma Private Limited offer?
Murli Krishna Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Pharmaceutical Pellets, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharmaceutical Excipients.
Who are the key members and board of directors at Murli Krishna Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Vadlamani  | Managing Director | 02-Apr-2004 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Kalyanasundaram | Director | 02-Apr-2004 | Current |
| Seetamahalaxmi Challa | Whole-Time Director | 02-Apr-2004 | Current |
| Nithyagovind | Nominee Director | 27-May-2020 | Current |
| Venkat Vadlamani | Director | 15-Jul-2024 | Current |
Financial Performance of Murli Krishna Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Murli Krishna Pharma?
Unlock access to Murli Krishna Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Murli Krishna Exports Private LimitedActive 25 years 3 monthsSeetamahalaxmi Challa and Satya Vadlamani are mutual person
Charges (Loans)
₹81.68 Cr
₹13.76 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 60.38 Cr
- Others : 20.00 Cr
- Axis Bank Limited : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2024 | Others | ₹10.00 Cr | Open |
| 28 Jun 2024 | Others | ₹10.00 Cr | Open |
| 04 Sep 2023 | Axis Bank Limited | ₹1.30 Cr | Open |
| 09 May 2023 | Hdfc Bank Limited | ₹2.30 M | Open |
| 25 Jan 2021 | Hdfc Bank Limited | ₹7.28 M | Open |
How Many Employees Work at Murli Krishna Pharma?
Unlock and access historical data on people associated with Murli Krishna Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Murli Krishna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Murli Krishna Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
